Citigroup’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-23,777
Closed -$75K 5429
2020
Q3
$75K Sell
23,777
-79,197
-77% -$250K ﹤0.01% 3286
2020
Q2
$300K Buy
102,974
+47,712
+86% +$139K ﹤0.01% 2869
2020
Q1
$156K Sell
55,262
-98,246
-64% -$277K ﹤0.01% 3007
2019
Q4
$498K Buy
153,508
+30,311
+25% +$98.3K ﹤0.01% 2637
2019
Q3
$266K Sell
123,197
-202,648
-62% -$438K ﹤0.01% 2925
2019
Q2
$1.02M Buy
325,845
+205,148
+170% +$644K ﹤0.01% 2122
2019
Q1
$449K Sell
120,697
-460,905
-79% -$1.71M ﹤0.01% 2584
2018
Q4
$1.69M Buy
581,602
+311,843
+116% +$905K ﹤0.01% 1637
2018
Q3
$709K Buy
269,759
+63,618
+31% +$167K ﹤0.01% 2253
2018
Q2
$483K Buy
206,141
+35,358
+21% +$82.8K ﹤0.01% 2385
2018
Q1
$502K Sell
170,783
-128,637
-43% -$378K ﹤0.01% 2312
2017
Q4
$820K Buy
299,420
+216,837
+263% +$594K ﹤0.01% 2021
2017
Q3
$280K Buy
82,583
+81,986
+13,733% +$278K ﹤0.01% 2779
2017
Q2
$1K Sell
597
-15,850
-96% -$26.5K ﹤0.01% 4846
2017
Q1
$37K Sell
16,447
-163,888
-91% -$369K ﹤0.01% 3817
2016
Q4
$382K Buy
180,335
+124,812
+225% +$264K ﹤0.01% 3112
2016
Q3
$186K Sell
55,523
-5,858
-10% -$19.6K ﹤0.01% 3023
2016
Q2
$193K Sell
61,381
-70,974
-54% -$223K ﹤0.01% 2898
2016
Q1
$441K Buy
132,355
+30,508
+30% +$102K ﹤0.01% 2797
2015
Q4
$360K Buy
101,847
+43,757
+75% +$155K ﹤0.01% 2617
2015
Q3
$293K Sell
58,090
-20,446
-26% -$103K ﹤0.01% 2567
2015
Q2
$504K Sell
78,536
-36,467
-32% -$234K ﹤0.01% 2148
2015
Q1
$809K Sell
115,003
-54,851
-32% -$386K ﹤0.01% 1917
2014
Q4
$1.31M Buy
169,854
+91,340
+116% +$704K ﹤0.01% 1571
2014
Q3
$587K Buy
78,514
+27,645
+54% +$207K ﹤0.01% 1915
2014
Q2
$492K Sell
50,869
-57,701
-53% -$558K ﹤0.01% 2007
2014
Q1
$902K Buy
108,570
+53,858
+98% +$447K ﹤0.01% 1649
2013
Q4
$461K Buy
54,712
+17,869
+49% +$151K ﹤0.01% 2422
2013
Q3
$293K Buy
36,843
+25,576
+227% +$203K ﹤0.01% 2325
2013
Q2
$88K Buy
+11,267
New +$88K ﹤0.01% 3389